Swiss National Bank - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 2 filers reported holding CYTOKINETICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$5,886,108
-8.7%
199,800
+1.1%
0.01%
+25.0%
Q2 2023$6,448,974
-5.5%
197,700
+1.9%
0.00%
-20.0%
Q1 2023$6,826,860
-31.0%
194,000
-10.2%
0.01%
-28.6%
Q4 2022$9,897,120
+5.8%
216,000
+11.9%
0.01%0.0%
Q3 2022$9,351,000
+26.8%
193,000
+2.8%
0.01%
+40.0%
Q2 2022$7,375,000
+12.2%
187,700
+5.2%
0.01%
+25.0%
Q1 2022$6,571,000
-12.8%
178,500
+8.0%
0.00%
-20.0%
Q4 2021$7,534,000
+30.1%
165,300
+2.0%
0.01%
+25.0%
Q3 2021$5,793,000
+134.5%
162,100
+29.9%
0.00%
+100.0%
Q2 2021$2,470,000
-27.0%
124,800
-14.2%
0.00%0.0%
Q1 2021$3,384,000
+13.5%
145,500
+1.4%
0.00%0.0%
Q4 2020$2,982,000
+1.1%
143,500
+5.4%
0.00%0.0%
Q3 2020$2,949,000
+11.6%
136,200
+21.5%
0.00%0.0%
Q2 2020$2,642,000
+130.1%
112,100
+15.1%
0.00%
+100.0%
Q1 2020$1,148,000
+13.4%
97,400
+2.1%
0.00%0.0%
Q4 2019$1,012,000
-3.4%
95,400
+3.6%
0.00%0.0%
Q3 2019$1,048,000
+7.6%
92,100
+6.4%
0.00%0.0%
Q2 2019$974,000
+46.7%
86,600
+5.5%
0.00%0.0%
Q1 2019$664,000
+27.9%
82,1000.0%0.00%0.0%
Q4 2018$519,000
-38.3%
82,100
-3.9%
0.00%0.0%
Q3 2018$841,000
+18.6%
85,4000.0%0.00%0.0%
Q2 2018$709,000
+32.8%
85,400
+15.2%
0.00%0.0%
Q1 2018$534,000
+0.6%
74,100
+13.7%
0.00%0.0%
Q4 2017$531,000
-43.8%
65,2000.0%0.00%0.0%
Q3 2017$945,000
+35.6%
65,200
+13.2%
0.00%0.0%
Q2 2017$697,00057,6000.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$41,198,0004.18%
Virtus ETF Advisers LLC 93,309$672,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 105,324$758,0000.55%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$19,065,0000.20%
WASATCH ADVISORS LP 1,761,882$12,686,0000.16%
PINNACLE ASSOCIATES LTD 888,415$6,397,0000.12%
ESSEX INVESTMENT MANAGEMENT CO LLC 84,690$610,0000.08%
Birchview Capital, LP 10,000$72,0000.05%
Piermont Capital Management Inc. 16,530$119,0000.04%
Tekla Capital Management LLC 137,797$992,0000.04%
View complete list of CYTOKINETICS INC shareholders